Novo Nordisk
NVO
NVO
1,653 hedge funds and large institutions have $30.1B invested in Novo Nordisk in 2024 Q4 according to their latest regulatory filings, with 206 funds opening new positions, 595 increasing their positions, 641 reducing their positions, and 290 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
24% less capital invested
Capital invested by funds: $39.6B → $30.1B (-$9.52B)
29% less first-time investments, than exits
New positions opened: 206 | Existing positions closed: 290
50% less funds holding in top 10
Funds holding in top 10: 62 → 31 (-31)
Holders
1,653
Holding in Top 10
31
Calls
$1.28B
Puts
$1.21B
Top Buyers
| 1 | +$478M | |
| 2 | +$254M | |
| 3 | +$227M | |
| 4 |
Two Sigma Investments
New York
|
+$159M |
| 5 |
ClearBridge Investments
New York
|
+$138M |
Top Sellers
| 1 | -$680M | |
| 2 | -$279M | |
| 3 | -$186M | |
| 4 |
IAIM
International Assets Investment Management
Orlando,
Florida
|
-$157M |
| 5 |
MIF
Mediolanum International Funds
Dublin 1,
Ireland
|
-$98.8M |